http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104016983-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104016983-B |
| titleOfInvention | Pyrrolo-triazine analog derivative and its preparation method and purposes |
| abstract | The present invention relates to pyrrolo-triazine analog derivative and its preparation methods and purposes.Specifically, pyrrolo-triazine analog derivative disclosed by the invention, with apparent tyrosine-kinase enzyme inhibition activity, it is effective tyrosine kinase inhibitor, it has broad application prospects and medical value to develop with low drug resistance or can alleviate the new type tyrosine kinase depressant object of early stage inhibitor drug resistance and provide new research direction and approach. |
| priorityDate | 2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 707.